Ovarian Cancer Targeted Medication: PARP Inhibitors, Anti-Angiogenic Drugs, Immunotherapy, and More Ovarian cancer is the malignancy with the highest rate of death from tumors of the female ...

Every minute, 38 people are diagnosed with cancer, and 18 people die from it globally, according to the World Health ...

Against all odds, in a victory of data over opinion, and after the determined work of the Health and Social Care Select ...

A new cancer Action Guide is equipping key stakeholders with targeted strategies to enhance efficiency and patient-centred ...

Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory for Digestive Health, National Clinical Research Center for Digestive Disease, Beijing ...

Researchers find blocking the KCNB2 gene can slow tumor growth, paving the way for next-gen treatments for childhood brain cancer.

New research published in Developmental Cell provides evidence that targeting the KCNB2 gene could enhance current cancer treatments, tackling medulloblastoma tumour growth. “Tumour-propagating cells ...

Background: Breast cancer remains a leading cause of mortality among women ... drug candidates with new mechanisms of action by targeting alternative signaling pathways. While hERG channel is ...

The National Testing Agency (NTA) has released important guidelines for candidates preparing for the JEE Main 2025. These guidelines aim to ensure a seamless and fair examination process. Adherence to ...

This treatment offers a distinct immunological pathway for SCC prevention ... of Dermatology and the Krantz Family Center for Cancer Research at Massachusetts General Hospital, said in a news ...

Cambridge Cancer Research Hospital is due to be built on the city's biomedical campus between 2025 and 2030. Hinchingbrooke Hospital, near Huntingdon, would also receive up to £1bn as part of ...